1. Home
  2. KELYA vs BCYC Comparison

KELYA vs BCYC Comparison

Compare KELYA & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc.

KELYA

Kelly Services Inc.

HOLD

Current Price

$16.09

Market Cap

340.1M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.00

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYA
BCYC
Founded
1946
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
340.1M
291.8M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
KELYA
BCYC
Price
$16.09
$4.00
Analyst Decision
Buy
Buy
Analyst Count
1
10
Target Price
$15.00
$13.90
AVG Volume (30 Days)
350.9K
309.6K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$5,355,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.60
N/A
P/E Ratio
$107.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.98
$3.75
52 Week High
$17.75
$9.16

Technical Indicators

Market Signals
Indicator
KELYA
BCYC
Relative Strength Index (RSI) 61.09 43.84
Support Level $8.48 $3.94
Resistance Level $16.20 $4.21
Average True Range (ATR) 0.71 0.14
MACD -0.05 0.00
Stochastic Oscillator 43.17 41.94

Price Performance

Historical Comparison
KELYA
BCYC

About KELYA Kelly Services Inc.

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: